Artificial IntelligenceHigh Priority (8/10)Usa

Anthropic Acquires Biotech Startup Coefficient Bio in $400 Million Deal

Anthropic has purchased AI biotech startup Coefficient Bio for $400 million, expanding its health and life sciences division following the October launch of Claude for Life Sciences.

Key Points

  • Acquisition valued at $400 million
  • Coefficient Bio had approximately 10 employees
  • Acquisition follows Anthropic's Claude for Life Sciences launch in October 2025
  • Team will join Anthropic's health and life science division

Full Details

Anthropic announced a $400 million acquisition of biotech startup Coefficient Bio, marking a significant expansion into healthcare and life sciences. The deal brings Coefficient's AI-driven drug discovery platform and its roughly ten-person team into Anthropic's growing life science division. This acquisition follows Anthropic's October launch of Claude for Life Sciences, a tool designed to help scientific researchers make discoveries. Coefficient Bio was using AI to improve efficiency in drug discovery and biological research. The team is expected to join Anthropic's health and life science team, strengthening the company's capabilities in applying large language models to scientific research and drug development.

Why It Matters

This acquisition signals Anthropic's serious commitment to the healthcare and life sciences vertical, competing directly with other AI companies expanding into drug discovery and medical research applications.

Sourcetechcrunch.com

Get stories like this delivered daily

AI-curated news, personalized to your interests. Zero noise.

Start 7-Day Free Trial →

More in Artificial Intelligence